Genetic Polymorphism of Mismatch Repair Genes and Susceptibility to Prostate Cancer

Mismatch repair (MMR) is one of the DNA repair systems that correct mispaired bases during DNA replication errors. Polymorphisms in genes can increase susceptibility to the development of prostate cancer (PCa). In this study, we investigated mutL homolog 1 (MLH1) -93G>A (rs1800734) and mutS homol...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Urology journal 2020-05, Vol.17 (3), p.271
Hauptverfasser: Khooshemehri, Paniz, Jamaldini, Seyed Hamid, Ziaee, Seyed Amir Mohsen, Afshari, Mahdi, Sattari, Mahshid, Narouie, Behzad, Sotoudeh, Mehdi, Montazeri, Vahideh, Sarhangi, Negar, Hasanzad, Mandana
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 3
container_start_page 271
container_title Urology journal
container_volume 17
creator Khooshemehri, Paniz
Jamaldini, Seyed Hamid
Ziaee, Seyed Amir Mohsen
Afshari, Mahdi
Sattari, Mahshid
Narouie, Behzad
Sotoudeh, Mehdi
Montazeri, Vahideh
Sarhangi, Negar
Hasanzad, Mandana
description Mismatch repair (MMR) is one of the DNA repair systems that correct mispaired bases during DNA replication errors. Polymorphisms in genes can increase susceptibility to the development of prostate cancer (PCa). In this study, we investigated mutL homolog 1 (MLH1) -93G>A (rs1800734) and mutS homolog 3 (MSH3) (rs26279) polymorphisms with the risk of PCa. In this study of Iranian population, 175 histopathologically confirmed (PCa) patients and 230 benign prostate hyperplasia (BPH) as the controls were recruited. The genotypes of MLH1 and MSH3 were determined by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) method. There was no significant difference of MLH1 (P = 0.4) and MSH3 (P?=?0.5) genotype distributions among PCa cases and controls. And also patients with PCa were not significant differences compared to those without in stage of cancer, grade of tumor, perineural invasion, and vascular invasion. Our results did not show adequate evidence for any significant association of MLH1 and MSH3 polymorphisms and PCa .
doi_str_mv 10.22037/uj.v0i0.5051
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_journals_2819508596</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2819508596</sourcerecordid><originalsourceid>FETCH-LOGICAL-p239t-3c35a86869098b4ada364a68ff7d6206f17d864d0b772362fd94c534a6dbe11f3</originalsourceid><addsrcrecordid>eNo10MFLwzAUBvAgipvTo1cJeO5M8po0PcrQKUwcTsFbSZuEZaxNTVJh_70V5-l7hx_f4z2ErimZM0aguBt282_iyJwTTk_QlBbAM56Lz9PjTIHICbqIcUdGAUScownQkoMEPkWbpelMcg1e-_2h9aHfuthib_HLmCo1W_xmeuUC_nURq07jzRAb0ydXu71LB5w8Xgcfk0oGL1TXmHCJzqzaR3N1zBn6eHx4Xzxlq9fl8-J-lfUMypRBA1xJIUVJSlnnSisQuRLS2kILRoSlhZYi16QuCgaCWV3mDYeR6NpQamGGbv96--C_BhNTtfND6MaVFZPjhUTyUozq5qiGujW66oNrVThU_z-AH2cbXcQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2819508596</pqid></control><display><type>article</type><title>Genetic Polymorphism of Mismatch Repair Genes and Susceptibility to Prostate Cancer</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Khooshemehri, Paniz ; Jamaldini, Seyed Hamid ; Ziaee, Seyed Amir Mohsen ; Afshari, Mahdi ; Sattari, Mahshid ; Narouie, Behzad ; Sotoudeh, Mehdi ; Montazeri, Vahideh ; Sarhangi, Negar ; Hasanzad, Mandana</creator><creatorcontrib>Khooshemehri, Paniz ; Jamaldini, Seyed Hamid ; Ziaee, Seyed Amir Mohsen ; Afshari, Mahdi ; Sattari, Mahshid ; Narouie, Behzad ; Sotoudeh, Mehdi ; Montazeri, Vahideh ; Sarhangi, Negar ; Hasanzad, Mandana</creatorcontrib><description>Mismatch repair (MMR) is one of the DNA repair systems that correct mispaired bases during DNA replication errors. Polymorphisms in genes can increase susceptibility to the development of prostate cancer (PCa). In this study, we investigated mutL homolog 1 (MLH1) -93G&gt;A (rs1800734) and mutS homolog 3 (MSH3) (rs26279) polymorphisms with the risk of PCa. In this study of Iranian population, 175 histopathologically confirmed (PCa) patients and 230 benign prostate hyperplasia (BPH) as the controls were recruited. The genotypes of MLH1 and MSH3 were determined by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) method. There was no significant difference of MLH1 (P = 0.4) and MSH3 (P?=?0.5) genotype distributions among PCa cases and controls. And also patients with PCa were not significant differences compared to those without in stage of cancer, grade of tumor, perineural invasion, and vascular invasion. Our results did not show adequate evidence for any significant association of MLH1 and MSH3 polymorphisms and PCa .</description><identifier>ISSN: 1735-1308</identifier><identifier>EISSN: 1735-546X</identifier><identifier>DOI: 10.22037/uj.v0i0.5051</identifier><identifier>PMID: 31953835</identifier><language>eng</language><publisher>Iran: Urology and Nephrology Research Center</publisher><subject>Aged ; Case-Control Studies ; DNA Mismatch Repair ; Genetic Predisposition to Disease ; Humans ; Iran ; Male ; Middle Aged ; MutL Protein Homolog 1 - genetics ; MutS Homolog 3 Protein - genetics ; Polymorphism ; Polymorphism, Restriction Fragment Length ; Prostate cancer ; Prostatic Neoplasms - genetics ; Yeast</subject><ispartof>Urology journal, 2020-05, Vol.17 (3), p.271</ispartof><rights>Copyright Urology and Nephrology Research Center May-Jun 2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31953835$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Khooshemehri, Paniz</creatorcontrib><creatorcontrib>Jamaldini, Seyed Hamid</creatorcontrib><creatorcontrib>Ziaee, Seyed Amir Mohsen</creatorcontrib><creatorcontrib>Afshari, Mahdi</creatorcontrib><creatorcontrib>Sattari, Mahshid</creatorcontrib><creatorcontrib>Narouie, Behzad</creatorcontrib><creatorcontrib>Sotoudeh, Mehdi</creatorcontrib><creatorcontrib>Montazeri, Vahideh</creatorcontrib><creatorcontrib>Sarhangi, Negar</creatorcontrib><creatorcontrib>Hasanzad, Mandana</creatorcontrib><title>Genetic Polymorphism of Mismatch Repair Genes and Susceptibility to Prostate Cancer</title><title>Urology journal</title><addtitle>Urol J</addtitle><description>Mismatch repair (MMR) is one of the DNA repair systems that correct mispaired bases during DNA replication errors. Polymorphisms in genes can increase susceptibility to the development of prostate cancer (PCa). In this study, we investigated mutL homolog 1 (MLH1) -93G&gt;A (rs1800734) and mutS homolog 3 (MSH3) (rs26279) polymorphisms with the risk of PCa. In this study of Iranian population, 175 histopathologically confirmed (PCa) patients and 230 benign prostate hyperplasia (BPH) as the controls were recruited. The genotypes of MLH1 and MSH3 were determined by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) method. There was no significant difference of MLH1 (P = 0.4) and MSH3 (P?=?0.5) genotype distributions among PCa cases and controls. And also patients with PCa were not significant differences compared to those without in stage of cancer, grade of tumor, perineural invasion, and vascular invasion. Our results did not show adequate evidence for any significant association of MLH1 and MSH3 polymorphisms and PCa .</description><subject>Aged</subject><subject>Case-Control Studies</subject><subject>DNA Mismatch Repair</subject><subject>Genetic Predisposition to Disease</subject><subject>Humans</subject><subject>Iran</subject><subject>Male</subject><subject>Middle Aged</subject><subject>MutL Protein Homolog 1 - genetics</subject><subject>MutS Homolog 3 Protein - genetics</subject><subject>Polymorphism</subject><subject>Polymorphism, Restriction Fragment Length</subject><subject>Prostate cancer</subject><subject>Prostatic Neoplasms - genetics</subject><subject>Yeast</subject><issn>1735-1308</issn><issn>1735-546X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNo10MFLwzAUBvAgipvTo1cJeO5M8po0PcrQKUwcTsFbSZuEZaxNTVJh_70V5-l7hx_f4z2ErimZM0aguBt282_iyJwTTk_QlBbAM56Lz9PjTIHICbqIcUdGAUScownQkoMEPkWbpelMcg1e-_2h9aHfuthib_HLmCo1W_xmeuUC_nURq07jzRAb0ydXu71LB5w8Xgcfk0oGL1TXmHCJzqzaR3N1zBn6eHx4Xzxlq9fl8-J-lfUMypRBA1xJIUVJSlnnSisQuRLS2kILRoSlhZYi16QuCgaCWV3mDYeR6NpQamGGbv96--C_BhNTtfND6MaVFZPjhUTyUozq5qiGujW66oNrVThU_z-AH2cbXcQ</recordid><startdate>20200501</startdate><enddate>20200501</enddate><creator>Khooshemehri, Paniz</creator><creator>Jamaldini, Seyed Hamid</creator><creator>Ziaee, Seyed Amir Mohsen</creator><creator>Afshari, Mahdi</creator><creator>Sattari, Mahshid</creator><creator>Narouie, Behzad</creator><creator>Sotoudeh, Mehdi</creator><creator>Montazeri, Vahideh</creator><creator>Sarhangi, Negar</creator><creator>Hasanzad, Mandana</creator><general>Urology and Nephrology Research Center</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20200501</creationdate><title>Genetic Polymorphism of Mismatch Repair Genes and Susceptibility to Prostate Cancer</title><author>Khooshemehri, Paniz ; Jamaldini, Seyed Hamid ; Ziaee, Seyed Amir Mohsen ; Afshari, Mahdi ; Sattari, Mahshid ; Narouie, Behzad ; Sotoudeh, Mehdi ; Montazeri, Vahideh ; Sarhangi, Negar ; Hasanzad, Mandana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p239t-3c35a86869098b4ada364a68ff7d6206f17d864d0b772362fd94c534a6dbe11f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aged</topic><topic>Case-Control Studies</topic><topic>DNA Mismatch Repair</topic><topic>Genetic Predisposition to Disease</topic><topic>Humans</topic><topic>Iran</topic><topic>Male</topic><topic>Middle Aged</topic><topic>MutL Protein Homolog 1 - genetics</topic><topic>MutS Homolog 3 Protein - genetics</topic><topic>Polymorphism</topic><topic>Polymorphism, Restriction Fragment Length</topic><topic>Prostate cancer</topic><topic>Prostatic Neoplasms - genetics</topic><topic>Yeast</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Khooshemehri, Paniz</creatorcontrib><creatorcontrib>Jamaldini, Seyed Hamid</creatorcontrib><creatorcontrib>Ziaee, Seyed Amir Mohsen</creatorcontrib><creatorcontrib>Afshari, Mahdi</creatorcontrib><creatorcontrib>Sattari, Mahshid</creatorcontrib><creatorcontrib>Narouie, Behzad</creatorcontrib><creatorcontrib>Sotoudeh, Mehdi</creatorcontrib><creatorcontrib>Montazeri, Vahideh</creatorcontrib><creatorcontrib>Sarhangi, Negar</creatorcontrib><creatorcontrib>Hasanzad, Mandana</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Middle East &amp; Africa Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Urology journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Khooshemehri, Paniz</au><au>Jamaldini, Seyed Hamid</au><au>Ziaee, Seyed Amir Mohsen</au><au>Afshari, Mahdi</au><au>Sattari, Mahshid</au><au>Narouie, Behzad</au><au>Sotoudeh, Mehdi</au><au>Montazeri, Vahideh</au><au>Sarhangi, Negar</au><au>Hasanzad, Mandana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Genetic Polymorphism of Mismatch Repair Genes and Susceptibility to Prostate Cancer</atitle><jtitle>Urology journal</jtitle><addtitle>Urol J</addtitle><date>2020-05-01</date><risdate>2020</risdate><volume>17</volume><issue>3</issue><spage>271</spage><pages>271-</pages><issn>1735-1308</issn><eissn>1735-546X</eissn><abstract>Mismatch repair (MMR) is one of the DNA repair systems that correct mispaired bases during DNA replication errors. Polymorphisms in genes can increase susceptibility to the development of prostate cancer (PCa). In this study, we investigated mutL homolog 1 (MLH1) -93G&gt;A (rs1800734) and mutS homolog 3 (MSH3) (rs26279) polymorphisms with the risk of PCa. In this study of Iranian population, 175 histopathologically confirmed (PCa) patients and 230 benign prostate hyperplasia (BPH) as the controls were recruited. The genotypes of MLH1 and MSH3 were determined by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) method. There was no significant difference of MLH1 (P = 0.4) and MSH3 (P?=?0.5) genotype distributions among PCa cases and controls. And also patients with PCa were not significant differences compared to those without in stage of cancer, grade of tumor, perineural invasion, and vascular invasion. Our results did not show adequate evidence for any significant association of MLH1 and MSH3 polymorphisms and PCa .</abstract><cop>Iran</cop><pub>Urology and Nephrology Research Center</pub><pmid>31953835</pmid><doi>10.22037/uj.v0i0.5051</doi></addata></record>
fulltext fulltext
identifier ISSN: 1735-1308
ispartof Urology journal, 2020-05, Vol.17 (3), p.271
issn 1735-1308
1735-546X
language eng
recordid cdi_proquest_journals_2819508596
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Aged
Case-Control Studies
DNA Mismatch Repair
Genetic Predisposition to Disease
Humans
Iran
Male
Middle Aged
MutL Protein Homolog 1 - genetics
MutS Homolog 3 Protein - genetics
Polymorphism
Polymorphism, Restriction Fragment Length
Prostate cancer
Prostatic Neoplasms - genetics
Yeast
title Genetic Polymorphism of Mismatch Repair Genes and Susceptibility to Prostate Cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T21%3A18%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Genetic%20Polymorphism%20of%20Mismatch%20Repair%20Genes%20and%20Susceptibility%20to%20Prostate%20Cancer&rft.jtitle=Urology%20journal&rft.au=Khooshemehri,%20Paniz&rft.date=2020-05-01&rft.volume=17&rft.issue=3&rft.spage=271&rft.pages=271-&rft.issn=1735-1308&rft.eissn=1735-546X&rft_id=info:doi/10.22037/uj.v0i0.5051&rft_dat=%3Cproquest_pubme%3E2819508596%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2819508596&rft_id=info:pmid/31953835&rfr_iscdi=true